In December 2010, the company began sales of the InSpectra TM StO2 Spot Check in countries that recognize the CE Mark and filed for marketing clearance of the product in the United States under the U.S. Food and Drug Administration's Premarket Notification, or 510(k), process. "This handheld device leverages our StO2 measurement technology and enables clinicians to quickly and cost-effectively identify at-risk patients, who can then be continuously monitored with the InSpectra StO2 Tissue Oxygenation Monitor," said Rick Penn, president of the BioMeasurement Division.
Penn also said that the clinical and economic evidence supporting wider adoption of StO2 monitoring continues to grow. "Multiple clinical studies demonstrate that patients with low StO2 are at risk of poor outcomes and that a significant percentage of patients in the emergency department and ICU have low StO2 even though their other vital signs are normal," said Penn. Additionally, independent study results were presented at the recent Society of Critical Care Medicine's 40 th Critical Care Congress showing how InSpectra StO2 was used to favorably guide resuscitation of shock patients and improve outcomes in the form of shortened length-of-stays in the ICU and hospital. Based on the compelling results of this initial study, the principal investigator is initiating an independent multi-site outcomes study to demonstrate these results in a larger population of patients.
Hutchinson Technology to Host Conference Call
The company will conduct a conference call and webcast for investors beginning at 4:00 p.m. Central Time on Tuesday, January 25. Individual investors and news media may participate in the conference call live via the webcast, which will be available through the Investor Relations page on Hutchinson Technology's web site at www.htch.com . Webcast participants will need to complete a brief registration form and should allow extra time before the webcast begins to register and, if necessary, download and install audio software.About Hutchinson Technology Hutchinson Technology is a global technology manufacturer committed to creating value by developing solutions to critical customer problems. The company's Disk Drive Components Division is a key worldwide supplier of suspension assemblies for disk drives. The company's BioMeasurement Division is focused on bringing new technologies and products to the market that provide information clinicians can use to improve the quality of health care and reduce costs.